Skip to main content

Table 1 Demographic and clinicopathological characteristics

From: A novel nutrition-related nomogram for the survival prediction of colorectal cancer-results from a multicenter study

Demographic or clinicopathological characteristic

Primary cohort

(N = 1373)

Internal validation cohort

(N = 409)

P value

No. of patients (%)

No. of patients (%)

 

General information

   

Age, > 65 years

421 (30.7)

122 (29.8)

0.795

Sex, male

803 (58.5)

247 (60.4)

0.528

Smoking status, yes

517 (37.7)

159 (38.9)

0.698

Alcohol consumption, yes

251 (18.3)

72 (17.6)

0.811

Tea consumption, yes

374 (27.2)

127 (31.1)

0.149

Comorbid disease(s)

  

0.932

 0

877 (63.9)

261 (63.8)

 

 1

377 (27.5)

109 (26.7)

 

 2

95 (6.9)

32 (7.8)

 

 3 or more

24 (1.7)

7 (1.7)

 

Family history of cancer, yes

193 (14.1)

58 (14.2)

1

TNM stage

  

0.378

 I

99 (7.2)

33 (8.1)

 

 II

344 (25.1)

116 (28.4)

 

 III

441 (32.1)

116 (28.4)

 

 IV

489 (35.6)

144 (35.2)

 

Radical resection, yes

539 (39.3)

163 (39.9)

0.874

Nutrition related information

   

PGSGA Criteria (nutritional index)

  

0.365

Well nourished (0–3)

449 (32.7)

149 (36.4)

 

Moderately malnourished (4–8)

537 (39.1)

149 (36.4)

 

Severely malnourished (> 9)

387 (28.2)

111 (27.1)

 

Weight loss, yes

685 (49.9)

207 (50.6)

0.842

Reduced intake, yes

588 (42.8)

163 (39.9)

0.874

Activities and function declined, yes

473 (34.5)

143 (35.0)

0.895

BMI, kg/m2

  

0.676

 < 18.5

153 (11.1)

40 (9.8)

 

 18.5–23.9

770 (56.1)

235 (57.5)

 

 24–27.9

367 (26.7)

114 (27.9)

 

 ≥ 28

83 (6.0)

20 (4.9)

 

Nutritional intervention, yes

334 (24.3)

99 (24.2)

1

Serum total protein, < 60 g/L

263 (19.2)

71 (17.4)

0.456

Serum albumin, < 35 g/L

373 (27.2)

92 (22.5)

0.608

  1. TNM stage, tumor-node-metastasis stage; PGSGA, patient generated subjective global assessment; BMI, body mass index